A fluorescent orthotopic bone metastasis model of human prostate cancer

Cancer Research

Volumn 59, Issue 4, 1999, Pages 781-786

  Yang, Meng ^a,b,c   Jiang, Ping ^a   Sun, Fang Xian ^a   Hasegawa, Satoshi ^a,b,c   Baranov, Eugene ^a   Chishima, Takashi ^c   Shimada, Hiroshi ^c   Moossa, A R ^b   Hoffman, Robert M ^a,b  

^a ANTICANCER INC   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE METASTASIS; CANCER GROWTH; CANCER MODEL; CANCER TRANSPLANTATION; CELL SUSPENSION; CONTROLLED STUDY; EXPERIMENTAL NEOPLASM; FLUORESCENCE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION;

ANIMALS; BONE NEOPLASMS; DISEASE MODELS, ANIMAL; FLUORESCENCE; GREEN FLUORESCENT PROTEINS; HUMANS; LUMINESCENT PROTEINS; MALE; MICE; MICE, INBRED BALB C; PROSTATIC NEOPLASMS;

EID: 0033557967     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Boring, C. C., Squines, T. S., Tong, T., and Montgomery, S. Cancer statistics. CA Cancer J. Clin., 44: 7-26, 1994.
2. Lepor, H., Ross, A., and Walsh, P. C. The influence of hormonal therapy or survival of men with advanced prostatic cancer. J. Urol., 128: 335-340, 1982.
3. Kozlowski, J. M., Fidler, I. J., Campbell, D., Xu, Z., Kaighn, M. E., and Hart, L. R. Metastatic behavior of human tumor cell lines grown in the nude mouse. Cancer Res., 44: 3522-3529, 1984.
4. Kaighn, M. E., Narayan, K. S., Ohnuki, Y., Lechner, J. F., and Jones, L. W. Establishment and characterization of a human prostate carcinoma cell line (PC-3). Invest. Urol., 17: 16-23, 1979.
5. Shevrin, D. H., Kukreja, S. C., Ghosh, L., and Lad, T. E. Development of skeletal metastasis by human prostate cancer in athymic nude mice. Clin. Exp. Metastasis, 6: 401-409, 1988.
6. Pettaway, C. A., Pathak, S., Greene, G., Ramirez, E., Wilson, M. R., Killion, J. J., and Fidler, I. J. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. Clin. Cancer Res., 2: 1627-1636, 1996.
7. Wu, T. T., Sike, R. A., Cui, Q., Thalmann, G. N., Kao, C., Murphy, C. F., Yang, H., Zhau, H. E., Balian, G., and Chung, L. W. Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines. Int. J. Cancer, 77: 887-894, 1998.
8. Stephenson, R. A., Dinney, C. P. N., Gohji, K., Ordonez, N. G., Killion, J. J., and Fidler, I. J. Metastasis model for human prostate cancer using orthotopic implantation in nude mice. J. Natl. Cancer Inst. (Bethesda), 84: 951-957, 1992.
9. Fu, X., Herrera, H., and Hoffman, R. M. Orthotopic growth and metastasis of human prostate carcinoma in nude mice after transplantation of histologically intact tissue. Int. J. Cancer, 52: 987-990, 1992.
10. Saito, N., Gleave, M. E., Bruchovshy, N., Rennie, P. S., Beraldi, E., and Sullivan, L. D. A metastatic and androgen-sensitive human prostate cancer model using intraprostatic inoculation of LNCaP cells in SCID mice. Cancer Res., 57: 1584-1589, 1997.
11. Rembrink, K., Romijn, J. C., van der Kwast, T. H., Rubben, H., and Schroder, F. H. Orthotopic implantation of human prostate cancer cell lines: a clinically-relevant animal model for metastatic prostate cancer. Prostate, 31: 168-174, 1997.
12. An, Z., Wang, X., Geller, J., Moossa, A. R., and Hoffman, R. M. Surgical orthotopic implantation allows high lung and lymph node metastatic expression of human prostate carcinoma cell line PC-3 in nude mice. Prostate, 34: 169-174, 1998.
13. Thalmann, G. N., Anezinis, P. E., Chang, S. M., Zhau, H. E., Kim, E. E., Hopwood, V. L., Pathak, S., Eschenbach, A. C. V., and Chung, W. K. Androgen-independent cancer progression and bone metastasis in the LNCaP model of human cancer. Cancer Res., 54: 2577-2581, 1994.
14. Chishima, T., Miyagi, Y., Wang, X., Yamaoka, H., Shimada, H., Moossa, A. R., and Hoffman, R. M. Cancer invasion and micrometastasis visualized in live tissue by green fluorescent protein expression. Cancer Res., 57: 2042-2047, 1997.
15. Chishima, T., Miyagi, Y., Wang, X., Tan, Y., Shimada, H., Moossa, A. R., and Hoffman, R. M. Visualization of the metastatic process by green fluorescent protein expression. Anticancer Res., 17: 2377-2384, 1997.
16. Chishima, T., Miyagi, Y., Wang, X., Baranov, E., Tan, Y., Shimada, H., Moossa, A. R., and Hoffman, R. M. Metastatic patterns of lung cancer visualized live and in process by green fluorescence protein expression. Clin. Exp. Metastasis, 15: 547-552, 1997.
17. Chishima, T., Miyagi, Y., Li, L., Tan, Y., Baranov, E., Yang, M., Shimada, H., Moossa, A. R., and Hoffman, R. M. Use of histoculture and green fluorescent protein to visualize tumor cell host interaction. In Vitro Cell Dev. Biol., 33: 745-747, 1997.
18. Chishima, T., Yang, M., Miyagi, Y., Li, L., Tan, Y., Baranov, E., Shimada, H., Moossa, A. R., and Hoffman, R. M. Governing step of metastasis visualized in vitro. Proc. Natl. Acad. Sci. USA, 94: 11573-11576, 1997.
19. Yang, M., Hasegawa, S., Jiang, P., Wang, X., Tan, Y., Chishima, T., Shimada, H., Moossa, A. R., and Hoffman, R. M. Widespread skeletal metastatic potential of human lung cancer revealed by green fluorescent protein expression. Cancer Res., 58: 4217-4221, 1998.
20. Dolman, C. S., Mueller, B. M., Lode, H. N., Xiang, R., Gillies, S. D., and Reisfeld, R. A. Suppression of human prostate carcinoma metastases in severe combined immunodeficient mice by interleukin-2 immunocytokine therapy. Clin. Cancer Res., 4: 2551-2557, 1998.
21. Wang, M., and Stearns, M. E. Isolation and characterization of PC-3 human prostatic tumor sublines which preferentially metastasize to select organs in SCID mice. Differentiation, 48: 115-125, 1991.
22. Wu, H. C., Hsieh, J. T., Gleave, M. E., Brown, N. M., Pathak, S., and Chung, L. W. Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells. Int. J. Cancer, 57: 406-412, 1994.
23. Soos, G., Zukowski, K., Jones, R. F., Haas, G. P., and Wang, C. Y. Heterotopic growth of human prostate carcinoma in the femurs of nude mice: an osseous metastatic model. Int. J. Cancer, 66: 280-281, 1996.
24. Klein, K., Reiter, R., Redulla, J., Moradi, H., Zhu, X., Brothman, A., Lamb, D., Marcelli, M., Bellegrun, A., Witte, O., and Sawyers, C. Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice. Nat. Med., 3: 402-408, 1997.
25. De la Monte, S. M., Moore, G. W., and Hutchins, G. M. Metastatic Behavior of prostate cancer. Cluster analysis of patterns with respect to estrogen treatment. Cancer (Phila.), 58: 985-993, 1986.
26. Mundy, G. R. Mechanisms of bone metastasis. Cancer (Phila.), 80: 1546-1556, 1997.
27. Lawrence, S. K., Van Buren, D. H., MacDonell, R. C., Jr., and Delbeke, D. Carcinoma in a transplanted kidney detected with MAG3 scintigraphy. J. Nucl. Med., 34: 2185-2187, 1993.
28. O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H., and Folkman, J. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell, 79: 315-328, 1994.